A pilot study on the inhibition of blood alcohol concentration increase after ingestion of peptides. - A pilot study on the inhibition of blood alcohol concentration increase after ingestion of peptides.

Suntory Global Innovation Center Ltd.0 个研究点目标入组 12 人开始时间: 2015年11月16日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1)Subjects whose systolic blood pressure is less than 90mmHg. 2)Subjects whose BMI is less than 20.0 and 23 or more. 3)Subjects who can't drink alcohol. 4)Subjects who are positive to alcohol patch test. 5)Subjects who drink alcohol a lot and smoke a lot. 6)Subjects who have an irregular sleep cycle, work shift or work on midnight shift 7)Subjects who constantly use supplements and/or functional foods (including Food for Specified Health Uses) affecting the test results. 8)Subjects who are participating in other clinical studies for drug medicine or food, or who finished clinical study within four weeks. 9)Subjects who are positive to hepatitis virus B, hepatitis virus C, HIV or human T-cell leukemia virus 10)Subjects who have allergic reaction to drug medicine and food. 11)Subject who are applicable to one of the below. a)Subject who are contracting heart, liver or kidney disease including the case of complicating disease. b)Subjects with a previous history of cardiovascular disease. c)Subjects who are contracting diabetes. 12)Subjects who donated 200 mL of blood and/or blood components within four weeks prior to the current study. 13)Subjects whose blood was collected more than 400 mL within the last twelve weeks. 14)Subjects whose blood was collected more than 1200 mL within the last twelve months when the amount of blood sampling in the current study is added. 15)Subjects who are judged as unsuitable for the study by the principal investigator for other reasons.

发起方

Suntory Global Innovation Center Ltd.